Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT04636814




Registration number
NCT04636814
Ethics application status
Date submitted
16/11/2020
Date registered
19/11/2020
Date last updated
19/09/2024

Titles & IDs
Public title
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Scientific title
A 52-week, Randomized, Double-blind, Double-dummy, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.
Secondary ID [1] 0 0
2020-003648-97
Secondary ID [2] 0 0
CLI-06001AA1-05
Universal Trial Number (UTN)
Trial acronym
PILLAR
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Chronic Obstructive Pulmonary Disease 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Other respiratory disorders / diseases
Infection 0 0 0 0
Other infectious diseases
Respiratory 0 0 0 0
Chronic obstructive pulmonary disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - CHF6001 1600µg
Treatment: Drugs - CHF6001 3200µg
Treatment: Drugs - Placebo
Treatment: Drugs - Roflumilast

Experimental: CHF6001 1600µg -

Experimental: CHF6001 3200µg -

Placebo comparator: Placebo -

Active comparator: Roflumilast -


Treatment: Drugs: CHF6001 1600µg
CHF6001 400µg, 2 inhalations bid (total daily dose of 1600µg) and Roflumilast matching placebo, 1 tablet once daily

Treatment: Drugs: CHF6001 3200µg
CHF6001 800µg, 2 inhalations bid (total daily dose of 3200µg) and Roflumilast matching placebo, 1 tablet once daily

Treatment: Drugs: Placebo
CHF6001 matching placebo, 2 inhalations bid and Roflumilast matching placebo, 1 tablet once daily

Treatment: Drugs: Roflumilast
- 1 tablet of Roflumilast (Daliresp®), 250µg, once daily during the first 4 weeks of treatment then 1 tablet of Roflumilast (Daliresp®), 500µg, once daily for the remaining treatment period and CHF6001 matching placebo, 2 inhalations bid
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
The number of moderate and severe exacerbations occurring during the planned 52-week treatment period.
Timepoint [1] 0 0
Up to 52 weeks
Secondary outcome [1] 0 0
The time to first moderate or severe exacerbation.
Timepoint [1] 0 0
Up to 52 weeks
Secondary outcome [2] 0 0
The annual rate of severe exacerbations.
Timepoint [2] 0 0
Up to 52 weeks
Secondary outcome [3] 0 0
The time to first severe exacerbation.
Timepoint [3] 0 0
Up to 52 weeks
Secondary outcome [4] 0 0
The number of all on-treatment severe exacerbations.
Timepoint [4] 0 0
Up to 52 weeks
Secondary outcome [5] 0 0
The number of all on-treatment exacerbations requiring systemic corticosteroids.
Timepoint [5] 0 0
Up to 52 weeks
Secondary outcome [6] 0 0
Change from baseline (pre-dose Visit 2) in pre-dose FEV1, at week 52.
Timepoint [6] 0 0
At week 52
Secondary outcome [7] 0 0
Change from baseline in Saint Georges Respiratory Questionnaire (SGRQ) total and domain scores at week 52.
Timepoint [7] 0 0
At week 52
Secondary outcome [8] 0 0
Saint Georges Respiratory Questionnaire response (SGRQ) (change from baseline SGRQ total score = -4) at week 52.
Timepoint [8] 0 0
At week 52
Secondary outcome [9] 0 0
Change from baseline to last inter-visit period (week 40-52) in EXACT-Respiratory Symptoms (E-RS) Total and subscale scores.
Timepoint [9] 0 0
Up to 52 weeks
Secondary outcome [10] 0 0
E-RS response (change from baseline E-RS Total score = -2) at week 52.
Timepoint [10] 0 0
At week 52
Secondary outcome [11] 0 0
Change from baseline to last inter-visit period (week 40-52) in the percentage of days without intake of rescue medication and in the average rescue medication use (number of puffs).
Timepoint [11] 0 0
Up to 52 weeks
Secondary outcome [12] 0 0
Time to study medication discontinuation for any reason.
Timepoint [12] 0 0
Up to 52 weeks
Secondary outcome [13] 0 0
Time to moderate or severe exacerbation or study medication discontinuation due to any adverse event, lack of efficacy or death (composite endpoint) and time to study medication discontinuation component.
Timepoint [13] 0 0
Up to 52 weeks
Secondary outcome [14] 0 0
Time to first moderate/severe exacerbation or study medication discontinuation due to any class-related AE, lack of efficacy, or death (composite endpoint) and time to study medication discontinuation component.
Timepoint [14] 0 0
Up to 52 weeks
Secondary outcome [15] 0 0
Key Secondary Variable: Change from baseline in SGRQ Total score at week 52
Timepoint [15] 0 0
At week 52

Eligibility
Key inclusion criteria
* Adults aged = 40 years, with COPD and with chronic bronchitis.
* Current smokers or ex-smokers (history of =10 pack years).
* Post-bronchodilator FEV1 <50% of the patient predicted normal value and FEV1/FVC ratio < 0.7.
* At least, one moderate or severe COPD exacerbation in the previous year.
* CAT score =10.
* Subjects on regular maintenance triple therapy for at least 12 months prior to screening and receiving regular maintenance triple therapy for at least 3 months prior to screening visit.
Minimum age
40 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Subjects with current asthma.
* Subjects with moderate or severe COPD exacerbation 4 weeks before study entry and randomisation
* Subjects with known a-1 antitrypsin deficiency as the underlying cause of COPD.
* Subjects with primary diagnosis of emphysema not related to COPD.
* Subjects with known respiratory disorders other than COPD.
* Subjects with lung volume reduction surgery.
* Subjects with active cancer or a history of lung cancer.
* Subjects under Roflumilast treatment within 6 months before study entry.
* Subjects with a diagnosis of depression, generalised anxiety disorder, suicidal ideation.
* Subjects with clinically significant cardiovascular condition.
* Subjects with neurological disease.
* Subjects with clinically significant laboratory abnormalities.
* Subjects with moderate or severe hepatic impairment.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
12/07/2021
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
18/09/2027
Actual
Sample size
Target
3980
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
Arkansas
Country [4] 0 0
United States of America
State/province [4] 0 0
California
Country [5] 0 0
United States of America
State/province [5] 0 0
Colorado
Country [6] 0 0
United States of America
State/province [6] 0 0
Florida
Country [7] 0 0
United States of America
State/province [7] 0 0
Georgia
Country [8] 0 0
United States of America
State/province [8] 0 0
Indiana
Country [9] 0 0
United States of America
State/province [9] 0 0
Louisiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Maryland
Country [11] 0 0
United States of America
State/province [11] 0 0
Massachusetts
Country [12] 0 0
United States of America
State/province [12] 0 0
Michigan
Country [13] 0 0
United States of America
State/province [13] 0 0
Mississippi
Country [14] 0 0
United States of America
State/province [14] 0 0
Missouri
Country [15] 0 0
United States of America
State/province [15] 0 0
Nebraska
Country [16] 0 0
United States of America
State/province [16] 0 0
Nevada
Country [17] 0 0
United States of America
State/province [17] 0 0
New Jersey
Country [18] 0 0
United States of America
State/province [18] 0 0
New York
Country [19] 0 0
United States of America
State/province [19] 0 0
North Carolina
Country [20] 0 0
United States of America
State/province [20] 0 0
Ohio
Country [21] 0 0
United States of America
State/province [21] 0 0
Oklahoma
Country [22] 0 0
United States of America
State/province [22] 0 0
Pennsylvania
Country [23] 0 0
United States of America
State/province [23] 0 0
South Carolina
Country [24] 0 0
United States of America
State/province [24] 0 0
Tennessee
Country [25] 0 0
United States of America
State/province [25] 0 0
Texas
Country [26] 0 0
United States of America
State/province [26] 0 0
Virginia
Country [27] 0 0
United States of America
State/province [27] 0 0
West Virginia
Country [28] 0 0
United States of America
State/province [28] 0 0
Wisconsin
Country [29] 0 0
Argentina
State/province [29] 0 0
Buenos Aires
Country [30] 0 0
Argentina
State/province [30] 0 0
Ciudad Autonoma Buenos Aires
Country [31] 0 0
Argentina
State/province [31] 0 0
Ciudad autónoma de Buenos Aires
Country [32] 0 0
Argentina
State/province [32] 0 0
Ciudad Autónoma de Buenos Aire
Country [33] 0 0
Argentina
State/province [33] 0 0
Córdoba
Country [34] 0 0
Argentina
State/province [34] 0 0
Florencio Varela
Country [35] 0 0
Argentina
State/province [35] 0 0
Florida
Country [36] 0 0
Argentina
State/province [36] 0 0
Mar Del Plata
Country [37] 0 0
Argentina
State/province [37] 0 0
Mendoza
Country [38] 0 0
Argentina
State/province [38] 0 0
Quilmes
Country [39] 0 0
Argentina
State/province [39] 0 0
Rosario
Country [40] 0 0
Argentina
State/province [40] 0 0
San Miguel De Tucumán
Country [41] 0 0
Argentina
State/province [41] 0 0
San Miguel de Tucumán
Country [42] 0 0
Argentina
State/province [42] 0 0
San Rafael
Country [43] 0 0
Argentina
State/province [43] 0 0
Santa Fe
Country [44] 0 0
Austria
State/province [44] 0 0
Feldbach
Country [45] 0 0
Austria
State/province [45] 0 0
Grieskirchen
Country [46] 0 0
Austria
State/province [46] 0 0
Linz
Country [47] 0 0
Austria
State/province [47] 0 0
Wels
Country [48] 0 0
Bosnia and Herzegovina
State/province [48] 0 0
Banja Luka
Country [49] 0 0
Bosnia and Herzegovina
State/province [49] 0 0
Bihac
Country [50] 0 0
Bosnia and Herzegovina
State/province [50] 0 0
Bijeljina
Country [51] 0 0
Bosnia and Herzegovina
State/province [51] 0 0
Foca
Country [52] 0 0
Bosnia and Herzegovina
State/province [52] 0 0
Gradiška
Country [53] 0 0
Bosnia and Herzegovina
State/province [53] 0 0
Mostar
Country [54] 0 0
Bosnia and Herzegovina
State/province [54] 0 0
Sarajevo
Country [55] 0 0
Bosnia and Herzegovina
State/province [55] 0 0
Travnik
Country [56] 0 0
Bosnia and Herzegovina
State/province [56] 0 0
Trebinje
Country [57] 0 0
Bosnia and Herzegovina
State/province [57] 0 0
Tuzla
Country [58] 0 0
Bosnia and Herzegovina
State/province [58] 0 0
Zenica
Country [59] 0 0
Bulgaria
State/province [59] 0 0
Blagoevgrad
Country [60] 0 0
Bulgaria
State/province [60] 0 0
Dimitrovgrad
Country [61] 0 0
Bulgaria
State/province [61] 0 0
Gabrovo
Country [62] 0 0
Bulgaria
State/province [62] 0 0
Haskovo
Country [63] 0 0
Bulgaria
State/province [63] 0 0
Kozloduy
Country [64] 0 0
Bulgaria
State/province [64] 0 0
Lovech
Country [65] 0 0
Bulgaria
State/province [65] 0 0
Montana
Country [66] 0 0
Bulgaria
State/province [66] 0 0
Pernik
Country [67] 0 0
Bulgaria
State/province [67] 0 0
Pleven
Country [68] 0 0
Bulgaria
State/province [68] 0 0
Plovdiv
Country [69] 0 0
Bulgaria
State/province [69] 0 0
Razgrad
Country [70] 0 0
Bulgaria
State/province [70] 0 0
Ruse
Country [71] 0 0
Bulgaria
State/province [71] 0 0
Sevlievo
Country [72] 0 0
Bulgaria
State/province [72] 0 0
Sofia
Country [73] 0 0
Bulgaria
State/province [73] 0 0
Stara Zagora
Country [74] 0 0
Bulgaria
State/province [74] 0 0
Vidin
Country [75] 0 0
Chile
State/province [75] 0 0
Concepcion
Country [76] 0 0
Chile
State/province [76] 0 0
Quillota
Country [77] 0 0
Chile
State/province [77] 0 0
Santiago
Country [78] 0 0
Chile
State/province [78] 0 0
Talca
Country [79] 0 0
Chile
State/province [79] 0 0
Valparaiso
Country [80] 0 0
Croatia
State/province [80] 0 0
Dubrovnik
Country [81] 0 0
Croatia
State/province [81] 0 0
Karlovac
Country [82] 0 0
Croatia
State/province [82] 0 0
Osijek
Country [83] 0 0
Croatia
State/province [83] 0 0
Rijeka
Country [84] 0 0
Croatia
State/province [84] 0 0
Sisak
Country [85] 0 0
Croatia
State/province [85] 0 0
Split
Country [86] 0 0
Croatia
State/province [86] 0 0
Zadar
Country [87] 0 0
Croatia
State/province [87] 0 0
Zagreb
Country [88] 0 0
Czechia
State/province [88] 0 0
Brandýs Nad Labem
Country [89] 0 0
Czechia
State/province [89] 0 0
Havlíckuv Brod
Country [90] 0 0
Czechia
State/province [90] 0 0
Jindrichuv Hradec
Country [91] 0 0
Czechia
State/province [91] 0 0
Miroslav
Country [92] 0 0
Czechia
State/province [92] 0 0
Mladá Boleslav
Country [93] 0 0
Czechia
State/province [93] 0 0
Mešice
Country [94] 0 0
Czechia
State/province [94] 0 0
Praha
Country [95] 0 0
Estonia
State/province [95] 0 0
Narva
Country [96] 0 0
Estonia
State/province [96] 0 0
Tallinn
Country [97] 0 0
Estonia
State/province [97] 0 0
Tartu
Country [98] 0 0
Germany
State/province [98] 0 0
Berlin
Country [99] 0 0
Germany
State/province [99] 0 0
Cottbus
Country [100] 0 0
Germany
State/province [100] 0 0
Darmstadt
Country [101] 0 0
Germany
State/province [101] 0 0
Delitzsch
Country [102] 0 0
Germany
State/province [102] 0 0
Frankfurt Am Main
Country [103] 0 0
Germany
State/province [103] 0 0
Geesthacht
Country [104] 0 0
Germany
State/province [104] 0 0
Hamburg
Country [105] 0 0
Germany
State/province [105] 0 0
Hannover
Country [106] 0 0
Germany
State/province [106] 0 0
Koblenz
Country [107] 0 0
Germany
State/province [107] 0 0
Leipzig
Country [108] 0 0
Germany
State/province [108] 0 0
Mainz
Country [109] 0 0
Germany
State/province [109] 0 0
Munich
Country [110] 0 0
Germany
State/province [110] 0 0
Peine
Country [111] 0 0
Greece
State/province [111] 0 0
Athens
Country [112] 0 0
Greece
State/province [112] 0 0
Chortiátis
Country [113] 0 0
Greece
State/province [113] 0 0
Heraklion
Country [114] 0 0
Greece
State/province [114] 0 0
Ioannina
Country [115] 0 0
Greece
State/province [115] 0 0
Thessaloníki
Country [116] 0 0
Greece
State/province [116] 0 0
Volos
Country [117] 0 0
Hungary
State/province [117] 0 0
Balassagyarmat
Country [118] 0 0
Hungary
State/province [118] 0 0
Budapest
Country [119] 0 0
Hungary
State/province [119] 0 0
Csorna
Country [120] 0 0
Hungary
State/province [120] 0 0
Edelény
Country [121] 0 0
Hungary
State/province [121] 0 0
Gödöllo
Country [122] 0 0
Hungary
State/province [122] 0 0
Monor
Country [123] 0 0
Hungary
State/province [123] 0 0
Nyíregyháza
Country [124] 0 0
Hungary
State/province [124] 0 0
Pécs
Country [125] 0 0
Hungary
State/province [125] 0 0
Sellye
Country [126] 0 0
Hungary
State/province [126] 0 0
Szeged
Country [127] 0 0
Hungary
State/province [127] 0 0
Szombathely
Country [128] 0 0
Hungary
State/province [128] 0 0
Törökbálint
Country [129] 0 0
Israel
State/province [129] 0 0
Ashkelon
Country [130] 0 0
Israel
State/province [130] 0 0
Be'er Sheva
Country [131] 0 0
Israel
State/province [131] 0 0
Hadera
Country [132] 0 0
Israel
State/province [132] 0 0
Haifa
Country [133] 0 0
Israel
State/province [133] 0 0
Jerusalem
Country [134] 0 0
Israel
State/province [134] 0 0
Kfar Saba
Country [135] 0 0
Israel
State/province [135] 0 0
Ramat Gan
Country [136] 0 0
Israel
State/province [136] 0 0
Tel Aviv
Country [137] 0 0
Korea, Republic of
State/province [137] 0 0
Anyang-si
Country [138] 0 0
Korea, Republic of
State/province [138] 0 0
Daegu
Country [139] 0 0
Korea, Republic of
State/province [139] 0 0
Dongjak
Country [140] 0 0
Korea, Republic of
State/province [140] 0 0
Gwangju
Country [141] 0 0
Korea, Republic of
State/province [141] 0 0
Haeundae
Country [142] 0 0
Korea, Republic of
State/province [142] 0 0
Incheon
Country [143] 0 0
Korea, Republic of
State/province [143] 0 0
Jeonju
Country [144] 0 0
Korea, Republic of
State/province [144] 0 0
Seoul
Country [145] 0 0
Korea, Republic of
State/province [145] 0 0
Suwon,Gyeonggi-do
Country [146] 0 0
Latvia
State/province [146] 0 0
Balvi
Country [147] 0 0
Latvia
State/province [147] 0 0
Daugavpils
Country [148] 0 0
Latvia
State/province [148] 0 0
Jurmala
Country [149] 0 0
Latvia
State/province [149] 0 0
Riga
Country [150] 0 0
Latvia
State/province [150] 0 0
Rezekne
Country [151] 0 0
Mexico
State/province [151] 0 0
Chihuahua
Country [152] 0 0
Mexico
State/province [152] 0 0
Cordoba
Country [153] 0 0
Mexico
State/province [153] 0 0
Cuauhtémoc
Country [154] 0 0
Mexico
State/province [154] 0 0
Guadalajara
Country [155] 0 0
Mexico
State/province [155] 0 0
Monterrey
Country [156] 0 0
Mexico
State/province [156] 0 0
Veracruz
Country [157] 0 0
Netherlands
State/province [157] 0 0
Beek
Country [158] 0 0
Netherlands
State/province [158] 0 0
Breda
Country [159] 0 0
Netherlands
State/province [159] 0 0
Heerlen
Country [160] 0 0
Netherlands
State/province [160] 0 0
Leeuwarden
Country [161] 0 0
New Zealand
State/province [161] 0 0
Christchurch
Country [162] 0 0
New Zealand
State/province [162] 0 0
Hamilton
Country [163] 0 0
New Zealand
State/province [163] 0 0
Tauranga
Country [164] 0 0
North Macedonia
State/province [164] 0 0
Bitola
Country [165] 0 0
North Macedonia
State/province [165] 0 0
Gevgelija
Country [166] 0 0
North Macedonia
State/province [166] 0 0
Ohrid
Country [167] 0 0
North Macedonia
State/province [167] 0 0
Shtip
Country [168] 0 0
North Macedonia
State/province [168] 0 0
Skopje
Country [169] 0 0
Poland
State/province [169] 0 0
Bialystok
Country [170] 0 0
Poland
State/province [170] 0 0
Gizycko
Country [171] 0 0
Poland
State/province [171] 0 0
Katowice
Country [172] 0 0
Poland
State/province [172] 0 0
Krakow
Country [173] 0 0
Poland
State/province [173] 0 0
Kraków
Country [174] 0 0
Poland
State/province [174] 0 0
Ostrowiec Swietokrzyski
Country [175] 0 0
Poland
State/province [175] 0 0
Poznan
Country [176] 0 0
Poland
State/province [176] 0 0
Sosnowiec
Country [177] 0 0
Poland
State/province [177] 0 0
Torun
Country [178] 0 0
Poland
State/province [178] 0 0
Wroclaw
Country [179] 0 0
Poland
State/province [179] 0 0
Lódz
Country [180] 0 0
Romania
State/province [180] 0 0
Bacau
Country [181] 0 0
Romania
State/province [181] 0 0
Brasov
Country [182] 0 0
Romania
State/province [182] 0 0
Cluj-Napoca Cluj
Country [183] 0 0
Romania
State/province [183] 0 0
Cluj-Napoca
Country [184] 0 0
Romania
State/province [184] 0 0
Cluj
Country [185] 0 0
Romania
State/province [185] 0 0
Constanta
Country [186] 0 0
Romania
State/province [186] 0 0
Craiova
Country [187] 0 0
Romania
State/province [187] 0 0
Iasi
Country [188] 0 0
Romania
State/province [188] 0 0
Oradea
Country [189] 0 0
Romania
State/province [189] 0 0
Resca
Country [190] 0 0
Romania
State/province [190] 0 0
Timisoara
Country [191] 0 0
Russian Federation
State/province [191] 0 0
Kazan
Country [192] 0 0
Russian Federation
State/province [192] 0 0
Moscow
Country [193] 0 0
Russian Federation
State/province [193] 0 0
Nizhniy Novgorod
Country [194] 0 0
Russian Federation
State/province [194] 0 0
Odintsovskiy
Country [195] 0 0
Russian Federation
State/province [195] 0 0
Saint Petersburg
Country [196] 0 0
Russian Federation
State/province [196] 0 0
Saint-Petersburg
Country [197] 0 0
Russian Federation
State/province [197] 0 0
Sankt-Peterburg
Country [198] 0 0
Russian Federation
State/province [198] 0 0
Saratov
Country [199] 0 0
Russian Federation
State/province [199] 0 0
Ulyanovsk
Country [200] 0 0
Russian Federation
State/province [200] 0 0
Voronezh
Country [201] 0 0
Russian Federation
State/province [201] 0 0
Vsevolozhsk
Country [202] 0 0
Russian Federation
State/province [202] 0 0
Yaroslavl
Country [203] 0 0
Serbia
State/province [203] 0 0
Belgrade
Country [204] 0 0
Serbia
State/province [204] 0 0
Jagodina
Country [205] 0 0
Serbia
State/province [205] 0 0
Kragujevac
Country [206] 0 0
Serbia
State/province [206] 0 0
Leskovac
Country [207] 0 0
Serbia
State/province [207] 0 0
Niš
Country [208] 0 0
Serbia
State/province [208] 0 0
Pancevo
Country [209] 0 0
Serbia
State/province [209] 0 0
Paracin
Country [210] 0 0
Serbia
State/province [210] 0 0
Sombor
Country [211] 0 0
Serbia
State/province [211] 0 0
Sremska Kamenica
Country [212] 0 0
Serbia
State/province [212] 0 0
Sremska Mitrovica
Country [213] 0 0
Serbia
State/province [213] 0 0
Užice
Country [214] 0 0
Serbia
State/province [214] 0 0
Valjevo
Country [215] 0 0
Slovakia
State/province [215] 0 0
Bardejov
Country [216] 0 0
Slovakia
State/province [216] 0 0
Košice
Country [217] 0 0
Slovakia
State/province [217] 0 0
Spišská Nová Ves
Country [218] 0 0
Spain
State/province [218] 0 0
Barcelona
Country [219] 0 0
Spain
State/province [219] 0 0
Cordoba
Country [220] 0 0
Spain
State/province [220] 0 0
Madrid
Country [221] 0 0
Spain
State/province [221] 0 0
Majadahonda
Country [222] 0 0
Spain
State/province [222] 0 0
Zaragoza
Country [223] 0 0
Turkey
State/province [223] 0 0
Adana
Country [224] 0 0
Turkey
State/province [224] 0 0
Bornova
Country [225] 0 0
Turkey
State/province [225] 0 0
Istanbul
Country [226] 0 0
Turkey
State/province [226] 0 0
Kocaeli
Country [227] 0 0
Turkey
State/province [227] 0 0
Mersin
Country [228] 0 0
Turkey
State/province [228] 0 0
Pamukkale
Country [229] 0 0
Turkey
State/province [229] 0 0
Pendik
Country [230] 0 0
Turkey
State/province [230] 0 0
Yenisehir
Country [231] 0 0
Turkey
State/province [231] 0 0
Çanakkale
Country [232] 0 0
Ukraine
State/province [232] 0 0
Dnipro
Country [233] 0 0
Ukraine
State/province [233] 0 0
Ivano-Frankivs'k
Country [234] 0 0
Ukraine
State/province [234] 0 0
Kharkiv
Country [235] 0 0
Ukraine
State/province [235] 0 0
Kharkov
Country [236] 0 0
Ukraine
State/province [236] 0 0
Kherson
Country [237] 0 0
Ukraine
State/province [237] 0 0
Kiev
Country [238] 0 0
Ukraine
State/province [238] 0 0
Kremenchuk
Country [239] 0 0
Ukraine
State/province [239] 0 0
Kyiv
Country [240] 0 0
Ukraine
State/province [240] 0 0
Odessa
Country [241] 0 0
Ukraine
State/province [241] 0 0
Poltava
Country [242] 0 0
Ukraine
State/province [242] 0 0
Vinnytsia
Country [243] 0 0
Ukraine
State/province [243] 0 0
Zaporizhia
Country [244] 0 0
United Kingdom
State/province [244] 0 0
Belfast
Country [245] 0 0
United Kingdom
State/province [245] 0 0
Bradford
Country [246] 0 0
United Kingdom
State/province [246] 0 0
London
Country [247] 0 0
United Kingdom
State/province [247] 0 0
Rochdale

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Chiesi Farmaceutici S.p.A.
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.
Trial website
https://clinicaltrials.gov/study/NCT04636814
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Fernando J. MARTINEZ, Prof.
Address 0 0
Weill Cornell Medical College, New York Presbyterian Hospital, 1305 York avenue box 96 NY 10021 USA
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Chiesi Clinical Trial info
Address 0 0
Country 0 0
Phone 0 0
+ 39 0521 2791
Fax 0 0
Email 0 0
[email protected]
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT04636814